Pterygium (eye growth/fleshy mass) surgery outcome assessment with a different technique.

Active, not recruiting

• Conditions: confirmed cases of PTERYGIUM growth in conjunctiva, any aye involved.from 18-60 years age.

• Registration Number: CTRI/2014/12/005279
• Lead Sponsor: Sri Guru Ram Rai Institute of Medical and Health Sciences and Sri Mahant Indiresh Hospital

Brief Summary

Aim of study:  To evaluate the outcome of suturefree, gluefree method of conjunctival autograft after pterygium excision.

Setting/design- prospective interventional Hospital based study.

We recruted 60 eyes from 60 patients who are having pterygium.Pterygium is graded, and surgical excision was performed by single surgeon followed by free conjunctival autograft was placed over the bare sclera using natural hemostasis to take place which can itself act as bioadhesive for the graft, thus avoiding the use of fibrin glue or sutures. Time and cost of surgery was assesed.Postoperatively patients were advised antibiotic (moxifloxacin 0.5%) eye drop,Steroid(loteprednol etabonate 0.5%) eye drop, and lubricant ( carboxymethylcellulose 1%)eye drop for 6 weeks.They were all atempted  for follow up on day1,7,15,30,120 and 180.At all postoperative visits thorough examination was done to see any recurrence of pterygium, any gradft dislodgement/displacement,complication related to surgery or graft or drugs.All outcome measures were tabulated.Primary outcome measures were1. recurrence of pterygium.2. graft adherence. Secondary outcme measures were 1. compication 2. symptom free interval 3.cost and time of surgery 4.cosmetic outcome 5.overall satisfaction.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01-06
• Last Update Posted: 2014-11-12

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

All patients who are having Pterygium (fibrovascular overgrowth of conjunctival tissue upon cornea) were enrolled in the study.

Exclusion Criteria

active conjunctival infection or inflammation, symblepharon, past ocular surgery or trauma within last 6 months, known diabetes mallitus, known collagen vascular disease, age below18 years and age above 60 years, pregnancy, any known bleeding disorder.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
recurrence rate, graft adherence	6 months

Secondary Outcome Measures

Name	Time	Method
intra or postoperative surgical complication, graft or drug related complication,cost of surgery, time of surgery,symptom free interval, overall satisfaction cosmesis.	upto 6 months

Trial Locations

Locations (1)

Department of Ophthalmology; 🇮🇳 Dehradun, UTTARANCHAL, India

Department of Ophthalmology

🇮🇳Dehradun, UTTARANCHAL, India

Sushobhan Dasgupta

Principal investigator

9557992400

dr_sushobhan@yahoo.co.in